According to the merger agreement reached by both parties, upon completion of the transaction, existing shareholders of Chemomab Therapeutics Ltd. are expected to own approximately 32% of the merged new company.

According to the merger agreement reached by both parties, upon completion of the transaction, existing shareholders of Chemomab Therapeutics Ltd. are expected to own approximately 32% of the merged new company.

老虎证券2026/07/08 11:51

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Meanwhile, the existing shareholders of Scipher Medicine are expected to receive approximately 68% of the shares in the new company. This equity distribution plan clarifies the control structure of the merged entity.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to the merger agreement reached by both parties, upon completion of the transaction, existing shareholders of Chemomab Therapeutics Ltd. are expected to own approximately 32% of the merged new company.

You may also like

Crypto prices